Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

BOLT Bolt Biotherapeutics Inc

1,12

0,00 (0,00%)

10 Mai 2024 - Geschlossen

Verzögert um 15 Minuten

Form 5 - Annual statement of changes in beneficial ownership of securities

Bolt Biotherapeutics (NASDAQ:BOLT)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more Bolt Biotherapeutics Charts.

Bolt Biotherapeutics (NASDAQ:BOLT)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more Bolt Biotherapeutics Charts.

News Bolt Biotherapeutics Inc

Bolt Biotherapeutics Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update
Donnerstag 21 März 2024 (2 Monate vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 6 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 6 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Bolt Biotherapeutics to Present at the TD Cowen 44th Annual Healthcare Conference
Dienstag 27 Februar 2024 (2 Monate vor) • GlobeNewswire Inc.

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Dienstag 13 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 5 - Annual statement of changes in beneficial ownership of securities
Dienstag 6 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Pacira Appoints Frank D. Lee as Chief Executive Officer
Donnerstag 21 Dezember 2023 (5 Monate vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 13 Dezember 2023 (5 Monate vor) • Edgar (US Regulatory)

Bolt Biotherapeutics Enrolls First Patient in Phase 2 Clinical Study Evaluating BDC-1001 in Patients with HER2-Positive Breast Cancer Previously Treated with Enhertu®
Dienstag 5 Dezember 2023 (5 Monate vor) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Donnerstag 9 November 2023 (6 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 9 November 2023 (6 Monate vor) • Edgar (US Regulatory)

Bolt Biotherapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
Donnerstag 9 November 2023 (6 Monate vor) • GlobeNewswire Inc.

Weitere Bolt Biotherapeutics Inc News-Artikel

Gold vs US Dollar

JP Morgan Chase

Invesco QQQ Trust Series 1

Euro vs US Dollar

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen